Vir Biotechnology, Inc. VIR Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s shares (diluted)?
- Vir Biotechnology, Inc. (VIR) reported shares (diluted) of 147.4M in Q1 2026.
- How has Vir Biotechnology, Inc.'s shares (diluted) changed year-over-year?
- Vir Biotechnology, Inc.'s shares (diluted) increased by 7.2% year-over-year, from 137.5M to 147.4M.
- What is the long-term trend for Vir Biotechnology, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s shares (diluted) has grown at a 1.1% compound annual growth rate (CAGR), from 528.8M to 553.4M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.